Therapeutic Financial Statements From 2010 to 2024
| TSOI Stock | USD 0.0005 0.0001 16.67% |
Check Therapeutic Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Therapeutic Solutions' main balance sheet or income statement drivers, such as , as well as many indicators such as . Therapeutic financial statements analysis is a perfect complement when working with Therapeutic Solutions Valuation or Volatility modules.
Therapeutic |
Therapeutic Solutions International Company Return On Equity Analysis
Therapeutic Solutions' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Therapeutic Solutions Return On Equity | -12.27 |
Most of Therapeutic Solutions' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Therapeutic Solutions International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Therapeutic Solutions International has a Return On Equity of -12.2676. This is 48.82% lower than that of the Healthcare sector and 66.35% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Therapeutic Solutions Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Therapeutic Solutions's current stock value. Our valuation model uses many indicators to compare Therapeutic Solutions value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Therapeutic Solutions competition to find correlations between indicators driving Therapeutic Solutions's intrinsic value. More Info.Therapeutic Solutions International is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Therapeutic Solutions by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Therapeutic Solutions' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Therapeutic Solutions Financial Statements
Investors use fundamental indicators, such as Therapeutic Solutions' revenue or net income, to determine how well the company is positioned to perform in the future. Although Therapeutic Solutions' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. Therapeutic Solutions International, Inc. was founded in 2007 and is based in Elk City, Idaho. Therapeutic Solutions operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Therapeutic Pink Sheet
Therapeutic Solutions financial ratios help investors to determine whether Therapeutic Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Therapeutic with respect to the benefits of owning Therapeutic Solutions security.